Teladoc Health (TDOC) Stock Forecast & Price Target

$9.44 +0.47 (+5.24%)

(As of 12/20/2024 05:40 PM ET)

Teladoc Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 21 Analyst Ratings

Sell
0

Hold
14

Buy
7

Based on 21 Wall Street analysts who have issued ratings for Teladoc Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 14 have given a hold rating, and 7 have given a buy rating for TDOC.

Consensus Price Target

$12.24
29.63% Upside

According to the 21 analysts' twelve-month price targets for Teladoc Health, the average price target is $12.24. The highest price target for TDOC is $19.00, while the lowest price target for TDOC is $8.00. The average price target represents a forecasted upside of 29.63% from the current price of $9.44.

Get the Latest News and Ratings for TDOC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Teladoc Health and its competitors.

TDOC Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)
Hold	14 Hold rating(s)	14 Hold rating(s)	14 Hold rating(s)	8 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$12.24	$12.08	$12.31	$27.14
Forecasted Upside	29.63% Upside	16.14% Upside	40.63% Upside	26.19% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem

TDOC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TDOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Teladoc Health Stock vs. The Competition

Type	Teladoc Health	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	29.63% Upside	25,828.59% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent TDOC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/4/2024	Piper Sandler 2 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$11.00 ➝ $13.00	+18.83%
11/15/2024	The Goldman Sachs Group 2 of 5 stars	D. Roman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00	+56.25%
11/1/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Boost Target	Hold ➝ Hold	$10.00 ➝ $12.00	+32.89%
10/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$9.00 ➝ $8.00	-11.89%
10/31/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$10.00 ➝ $12.00	+32.16%
10/9/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$9.00 ➝ $10.00	+11.48%
Get the Latest News and Ratings for TDOC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.
10/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$8.00 ➝ $9.00	+3.09%
9/17/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$8.00 ➝ $10.00	+22.47%
8/26/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$16.00 ➝ $9.00	+22.45%
8/20/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$10.00 ➝ $10.00	+39.28%
8/2/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$15.00 ➝ $10.00	+21.80%
8/1/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold
8/1/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$12.00 ➝ $8.00	-8.88%
8/1/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$16.00 ➝ $9.00	+2.51%
8/1/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$25.00 ➝ $17.00	+92.96%
8/1/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$21.00 ➝ $17.00	+120.21%
5/14/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$16.50 ➝ $13.50	+5.55%
4/29/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$17.00 ➝ $15.00	+12.53%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$17.00	+17.24%
2/21/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$21.00 ➝ $19.00	+23.46%
4/28/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
4/27/2023	VNET Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
4/27/2023	58.com Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains
4/11/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Equal Weight	$25.00	-4.80%
3/10/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$30.00 ➝ $27.00	+12.13%
2/23/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$34.00	+15.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:33 AM ET.

TDOC Forecast - Frequently Asked Questions

: According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Teladoc Health is $12.24, with a high forecast of $19.00 and a low forecast of $8.00.
: 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 14 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
: According to analysts, Teladoc Health's stock has a predicted upside of 29.63% based on their 12-month stock forecasts.
: Teladoc Health has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Evercore ISI, Piper Sandler, Royal Bank of Canada, TD Cowen, and The Goldman Sachs Group in the past 90 days.
: Analysts like Teladoc Health less than other "medical" companies. The consensus rating for Teladoc Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TDOC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Why I'm telling friends to avoid gold stocks (Ad)

Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."

And if you’d like to get your hands on this, here you go, the complete breakdown.

This page (NYSE:TDOC) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teladoc Health (TDOC) Stock Forecast & Price Target